Skip to main content

Neeti Wilson speaks on ‘Patents, Innovation and Access to New Pharmaceuticals’ at the National Conference on IPR in Health Sciences organised by Amity University.

The two day conference, attended by over 150 participants, brought together speakers from the legal fraternity, government, and luminaries from the scientific community and academia.

Neeti spoke about the International System of Patenting and Indian patent law, with a focus on Section 3(d) of the Patents Act 1970.

In addition to talks on pharmaceutical patents and the role of regulation in health sciences, the conference envisaged discussion on topics ranging widely from IP in traditional medicine to patenting of cutting-edge medical developments such as regenerative medicines and stem cell research.neeti wilson amity university national conference ipr health sciences

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
Jul 17, 2026

First published by Lexology. Authors: Sandhya Singh and Sampada Kapoor Modern sport is no longer merely an athletic competition; it is a multi-billion-dollar

Managing Ambush Marketing: Legal and Commercial Perspectives
News & Updates, Thought Leadership
Jul 08, 2026

‘First published on Enterprise IT World’ Author: Subroto Kumar Panda The digital ecosystem is undergoing an architectural segment change. For more

The Shift to Non-Human Digital Infrastructure: Orchestration, Self-Healing, and the Agentic Frontier
Thought Leadership
Jun 26, 2026

‘First published on WTR’By: Saif Khan and Prajjwal Kushwaha Legal framework Trademarks Act 1999 The Trademarks Act is the parent statutory regulation

India: courts adopt new ways to protect brand owners by permanent blocking of fraudulent domains and asset freezing 
News & Updates, Thought Leadership
Jun 16, 2026

First published by Lexology. Authors: Pravin Anand and Dr. Neeti Wilson Introduction India’s biodiversity is one of its greatest strategic assets.

India’s Biodiversity Framework at a Crossroads: Industry Perspectives on the Biological Diversity Act and ABS Regulations, 2025